GeminIQ Website Logo

Viewing BIXT free

Subscribe for full history, 50+ metrics, screener, watchlist...

BIOXYTRAN, INC

BIXT

Companies in Pharmaceutical Preparations

BIOXYTRAN, INC (BIXT) — SEC Financial Statements & Analysis

BIOXYTRAN, INC (BIXT) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Cash
010000000000
Assets Current
Assets Current
010000000000
Prepaid Expense Current
-0----------
Finite Lived Patents Gross
------0-----
Assets Noncurrent
------0-----
Finite Lived Intangible Assets Net
000000-00000
Assets
110000000000
Liabilities And Stockhold…
Accounts Payable And Accrued Liabilities Current
11--10000001
Deferred Compensation Share Based Arrangements Lia…
-----------0
Liabilities Current
Liabilities Current
533332111323
Loans Payable Current
0-----------
Other Short Term Borrowings
000000------
Derivative Liabilities Current
000110------
Convertible Notes Payable Current
111111-11222
Liabilities
533332111323
Preferred Stock Value
0000000-----
Stockholders Equity
Stockholders Equity
-4-3-3-3-3-2-1-1-1-3-2-3
Common Stock Value
000000000000
Additional Paid In Capital Common Stock
------17---13-
Additional Paid In Capital
191817171717-1616131311
Minority Interest
--------1-1-1-1-1
Retained Earnings Accumulated Deficit
-23-21-21-20-20-19-18-17-16-16-15-13
Liabilities And Stockholders Equity
110000000000
Preferred Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Preferred Stock Shares Authorized
505050505050505050505050
Preferred Stock Shares Issued
43434343434329-----
Preferred Stock Shares Outstanding
43434343434329-----
Common Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Common Stock Shares Authorized
400400400400400400300300300300300300
Common Stock Shares Issued
227216178178178174164177173145144132
Shares Outstanding
227216178178178174164177173145144132

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-6.67%-24.67%----------
20253.85%-23.08%-30.77%-7.91%-17.36%-18.89%11.70%2.92%-39.03%-6.30%-16.76%-32.81%
2024-16.53%-8.30%-34.34%-18.35%12.00%-7.00%-3.03%-11.11%-19.80%28.65%20.32%-13.49%
2023---24.08%43.81%19.80%-16.99%2.17%-23.31%30.43%-3.83%5.65%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
0.09
0.16
0.00
0.00
0.00
0.00
0.03
0.01
0.01
0.01
0.03
0.02
Quick Ratio
0.09
0.16
0.00
0.00
0.00
0.00
0.03
0.01
0.01
0.01
0.03
0.02
Working Capital
-4.55M
-2.74M
-3.05M
-2.78M
-2.84M
-1.93M
-1.21M
-1.21M
-1.11M
-3.22M
-2.25M
-2.72M
Leverage & Debt
Debt to Equity
-1.14
-1.25
-1.05
-1.06
-1.05
-1.08
-1.15
-1.12
-1.13
-1.04
-1.09
-1.04
Debt Ratio
8.14
4.93
19.58
18.87
20.90
13.92
7.82
9.56
8.89
23.28
12.34
19.36
Efficiency & Turnover
Asset Turnover TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Per Share Metrics
Diluted EPS TTM
-0.03
-0.02
-0.03
-0.03
-0.04
-0.02
-0.02
-0.02
-0.03
-0.03
-0.03
-0.03
Free Cash Flow Per Share TTM
-0.01
-0.01
-0.01
-0.01
-0.01
-0.00
-0.00
-0.00
-0.00
-0.01
-0.01
-0.01
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Growth Metrics
Net Income Growth (1Y)
-10.55%
-10.80%
-14.30%
-28.47%
-25.30%
-46.79%
-35.36%
4.83%
70.72%
67.73%
31.20%
-8.45%
EPS Growth (1Y)
-29.22%
34.62%
21.72%
42.19%
37.43%
-48.56%
-30.22%
-23.54%
28.99%
41.11%
11.92%
-21.22%
Valuation Metrics
P/E TTM
-1.78
-3.28
-2.67
-3.76
-3.95
-5.24
-5.04
-4.92
-4.07
-4.49
-5.43
-7.41
P/B
-1.15
-2.69
-2.18
-3.53
-4.63
-6.95
-12.82
-15.48
-17.46
-6.47
-10.82
-9.19
Market Cap
5.04M
6.96M
6.32M
9.31M
12.54M
12.46M
13.90M
17.02M
17.29M
20.10M
23.20M
24.47M
Enterprise Value
5.74M
7.26M
7.11M
10.11M
13.34M
13.26M
13.87M
17.74M
18.14M
21.97M
25.02M
26.43M
Calculated Values
Free Cash Flow TTM
-630.05K
-549.55K
-446.34K
-487.56K
-462.67K
-410.90K
-370.08K
-640.98K
-743.64K
-819.68K
-877.28K
-1.25M
Net Debt
697.55K
295.09K
790.50K
801.86K
800.65K
799.85K
-34.67K
716.48K
851.48K
1.87M
1.82M
1.95M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2025-11-18Purchase
Owner: Hoberman, Alan M
Title: -
Shares: 210,000
Price/Share: $0.60
Value: $126,000.00
Shares Owned: 210,000
Relationship: Director
Ownership: Direct
2024-08-15Purchase
Owner: Platt, David
Title: CEO
Shares: 1,592,921
Price/Share: $0.12
Value: $191,150.52
Shares Owned: 21,675,939
Relationship: Director,Officer,TenPercentOwner
Ownership: Indirect

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2018-06-30
0.01%
Inst. Shares: 25,000
Shares Outstanding: 331,309,050
2018-03-31
0.01%
Inst. Shares: 25,000
Shares Outstanding: 316,249,050
2017-12-31
0.01%
Inst. Shares: 25,000
Shares Outstanding: 340,414,692
2017-09-30
0.01%
Inst. Shares: 25,000
Shares Outstanding: 314,247,150
2017-06-30
0.01%
Inst. Shares: 25,000
Shares Outstanding: 314,247,150

Research Faster.
Invest Smarter.

BIOXYTRAN, INC (BIXT) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.